期刊文献+

新生儿溶血病检测试验多样性与胆红素水平相关性研究 被引量:4

Research on the relevance between different results of hemolysis detection tests and serum bilirubin levels of hemolytic disease of the newborn
原文传递
导出
摘要 目的探讨新生儿ABO溶血病(ABO.HDN)溶血三项试验不同结果与胆红素水平的相关性。方法对85例ABO—HDN患儿进行血清溶血三项试验[抗人球蛋白试验(DAT)、游离抗体试验、抗体释放试验]、母亲IgG抗A(B)抗体、血清胆红素等测定。结果ABO.HDN患儿DAT阳性者血清总胆红素峰值与DAT阴性者比较,差异有统计学意义(P〈0.05,0.01);DAT阴性间比较、DAT阳性问比较(P〉0.05),差异无统计学意义。新生儿ABO.HDN患儿母亲血型抗体与血清总胆红素水平比较,差异无统计学意义(P〉0.05)。结论ABO-HDN患儿DAT阳性合并抗体释放试验阳性或三项试验均阳性时,血清胆红素水平增高较明显,DAT阴性释放试验和/或游离试验阳性时,新生儿ABO-HDN相对较轻,而母亲IgG抗体效价高低不能反映HDN的严重程度,这可为临床合理治疗HDN提供帮助。 Objective To study the relevance between different results of three hemolysis detection tests and serum bilirubin levels of ABO hemolytic disease of the newborn (ABO-HDN). Methods Serological hemolysis three tests (direct anti-human globulin test, free antibody test, antibody release test), maternal anti-A (B) IgG antibodies, serum bilirubin were examined in 85 cases of ABO-HDN. Results There were significant differences in levels of total serum bilirubin(TSB) between groups of DAT-positive and groups of DAT-negative (P 〈0.05 ,or P 〈 0. 01 ). There weren' t signifieants difference between groups of DAT-positive or groups of DAT-negative in levels of total serum bilirubin (P 〉 0. 05 ). There wasn' t significant difference between maternal antibodies titer and levels of total serum bilirubin ( P 〉 0. 05 ). Conclusion When DAT is positive, the serum bilirubin level was significantly increased, and maternal antibodies titer eouldn' t show severity of ABO-HDN. It could be helpfull for the clinical treatment of ABO-HDN.
出处 《中国临床实用医学》 2010年第5期24-26,共3页 China Clinical Practical Medicine
基金 滕州市2009科技发展计划(项目编号:2009048)
关键词 新生儿溶血病 抗人球蛋白试验 游离抗体试验 抗体释放试验 血清胆红素 IGG抗A(B) ABO hemolytic disease of the newborn direct anti-human globulin test Free antibody test Antibody release test Serum bilirubin Anti-A ( B ) IgG antibody
  • 相关文献

参考文献14

  • 1Lange MM, Dicagno L, Castello D. Hemolytic disease of the new born due to ABO isoimmunization. Diagnostic and therapeutic con- siderations. Minerva Pediatr, 1964,16:34-43.
  • 2Cianciarullo M A, Ceccon M E, Vaz F A. Prevalence of immunohematologic tests at birth and the incidence of hemolytic disease in the newborn. Rev Assoc Med Bras ,2003,49 (1) :45-53.
  • 3Drabik-Clary K,Reddy W,Benjamin WH,et al. Severe hemolytic disease of the newborn in a group B Mrican-Ameriean infant delivered by a group 0 mother. Ann Clin Lab Sci, 2006,36 (2) :205-207.
  • 4Goraya J, Basu S, Sodhi P, et al. Unusually severe ABO hemolytic disease of newborn. Indian J Pediatr,2001,68 (3) :285-286.
  • 5Miqdad AM, Abdelbasit OB, Shaheed MM, et al. Intravenous immunoglobulin G ( IVIG ) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med,2004,16 ( 3 ) : 163-166.
  • 6Juretschke LJ. Kernicterus: StiU a concern. Neonatal Netw,2005,24 (2) :7-19.
  • 7American Academy of Pediatrics Clinical Practice Guideline Subcommittee on Hyperbilirubinemia. Mangagement of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics,2004,114 ( 1 ) :297-316.
  • 8New guideline for management of hyperbilirubinemia in newborns, Adv Neonatal Care, 2004,4 ( 4 ) : 225.
  • 9Brumit MC, Stubbs JR. Conventional tube agglutination withpolye thy lene glycol versus Red cell Affinity column Technolgy ( ReACT) :a comparison of anltibody detection methods. Ann Clin Lab Sci,2002,32(2) :155-158.
  • 10赵淑娟,贺雷.新生儿ABO溶血病的早期观察[J].中国保健,2008,16(3):47-47. 被引量:2

二级参考文献5

共引文献17

同被引文献41

  • 1陈玫,王慧,毕晓琳,叶萍,胡荣花.新生儿血清中抗-A(B)IgG亚类与ABO溶血症的关系[J].中国输血杂志,2006,19(2):126-128. 被引量:7
  • 2杨锡强,易若文主编.儿科学.6版.北京:人民卫生出版社,2006:124.
  • 3胡丽华.临床输血检验[M].2版.北京:中国医药科技出版社,2010:52-53.
  • 4苏湘晖,粟玉萍,代敏,等.119例新生儿溶血病血清学检测结果分析[J].医学信息,2013,26(12):269-270.
  • 5MaiseIs MJ, McDonagh AF. Phototherapy for neonatal Jaundice [ J]. N Engl J Med ,2008,358 (9) :920-928.
  • 6Drabik-Clary K, Reddy VV, Beniamin WH, et al. Severe hemolytic disease of the newborn in a group B African-American infant de- livered by a group O mother[J]. Ann Clin Lab Sci,2006,36(2) : 205-207.
  • 7Brossard Y, Parnet-Mathieu F, Larsen M. Incompatibilites fetal maternelles erythrocytaires[J]. Transfusion Sanguine: Une Ap- proche Securitaire, 2000,4 (1) : 290-318.
  • 8Cohen DN, Johnson MS, Liang WH, et al. Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG [J]. Transfusion, 2014,54(11):2863- 2866.
  • 9Higel L, Froehlich C, Pages MP, et al. Macrophage activation syndrome and autoimmunity due to visceral leishmaniasis[J].Arch Pediatr,2015,22(4):397-400.
  • 10Wolanin SA, Demain JG, Meier EA. Successful desensitization of a patient with aplastic anemia to antithymocyte globulin [J].Allergy Rhinol (Providence),2015,6(1):64-67.

引证文献4

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部